Relationship Between Nutritional Status and Clinical Outcome in Patients With Gastrointestinal Stromal Tumor After Surgical Resection
Overview
Authors
Affiliations
Background: Currently, gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors in the gastrointestinal tract, and surgical resection is the main treatment. Malnutrition after gastrointestinal surgery is not uncommon, which may have adverse effects on postoperative recovery and prognosis. However, the nutritional status of GIST patients after surgical resection and its impact on clinical outcomes have received less attention. Therefore, the aim of this study was to dynamically evaluate the nutritional status of GIST patients undergoing surgical resection, and to analyze the correlation between nutritional status and clinical outcomes.
Methods: We retrospectively analyzed the clinical data of GIST patients who underwent surgical resection in the Fourth Hospital of Hebei Medical University from January 2016 to January 2020. Nutritional risk screening 2002 (NRS2002) and Patient-Generated Subjective Global Assessment (PG-SGA) were used to assess the nutritional status of all patients at admission and discharge, and the correlation between nutritional risk and clinical outcomes was analyzed.
Results: A total of 413 GIST patients were included in this study, among which 114 patients had malnutrition risk at admission (NRS2002 score ≥ 3), and 65 patients had malnutrition (PG-SGA score ≥ 4). The malnutrition risk rate (27.60 vs. 46.73%, < 0.001) and malnutrition incidence (15.73 vs. 37.29%, < 0.001) at admission were lower than those at discharge. Compared with the laboratory results at admission, the albumin, prealbumin, and total protein of the patients at discharge were significantly lower (all < 0.05). And there was a negative correlation between PG-SGA and clinical outcome (all < 0.05).
Conclusion: The nutritional status of GIST patients after surgical resection at discharge was worse than that at admission, and malnutrition is an important risk factor leading to poor clinical outcomes.
Tang W, Li C, Huang D, Zhou S, Zheng H, Wang Q Cancer Biol Ther. 2024; 25(1):2358551.
PMID: 38813753 PMC: 11141475. DOI: 10.1080/15384047.2024.2358551.
Chen Z, Hong B, He J, Ye Q, Hu Q World J Gastrointest Surg. 2023; 15(10):2222-2233.
PMID: 37969702 PMC: 10642466. DOI: 10.4240/wjgs.v15.i10.2222.
Ding P, Wu J, Wu H, Sun C, Guo H, Lowe S BMC Gastroenterol. 2023; 23(1):23.
PMID: 36690935 PMC: 9869595. DOI: 10.1186/s12876-023-02658-x.
Prognostic Nomogram for Gastrointestinal Stromal Tumors after Surgery Based on the SEER Database.
Sun Q, Chen Y, Li T, Zhu X, Zhu G, Ni B Biomed Res Int. 2022; 2022:5639174.
PMID: 36420093 PMC: 9678471. DOI: 10.1155/2022/5639174.
Ding P, Guo H, Sun C, Chen S, Yang P, Tian Y Front Nutr. 2022; 9:963265.
PMID: 36118766 PMC: 9478187. DOI: 10.3389/fnut.2022.963265.